Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity
about
Novel Immunotherapeutic Approaches for Head and Neck Squamous Cell CarcinomaA phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study.The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activation.Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.TLR8 ligation induces apoptosis of monocytic myeloid-derived suppressor cells.
P2860
Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Coordinated Activation of Toll ...... l Natural Killer Cell Activity
@ast
Coordinated Activation of Toll ...... l Natural Killer Cell Activity
@en
type
label
Coordinated Activation of Toll ...... l Natural Killer Cell Activity
@ast
Coordinated Activation of Toll ...... l Natural Killer Cell Activity
@en
prefLabel
Coordinated Activation of Toll ...... l Natural Killer Cell Activity
@ast
Coordinated Activation of Toll ...... l Natural Killer Cell Activity
@en
P2093
P2860
P1433
P1476
Coordinated Activation of Toll ...... l Natural Killer Cell Activity
@en
P2093
Chihiro Morishima
Gregory N Dietsch
Hailing Lu
Laura Q Chow
Mary L Disis
Robert M Hershberg
P2860
P304
P356
10.1371/JOURNAL.PONE.0148764
P407
P577
2016-02-29T00:00:00Z